EXPRESS: Dual Eta/Etb Blockade With Macitentan Improves Both Vascular Remodelling and Angiogenesis in Pulmonary Arterial Hypertension

Pulmonary Circulation - United States
doi 10.1177/2045893217741429
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

A Focus on Macitentan in the Treatment of Pulmonary Arterial Hypertension

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2018English

EXPRESS: Metabolomics of Exercise Pulmonary Hypertension Are Intermediate Between Controls and Patients With Pulmonary Arterial Hypertension

Pulmonary Circulation
PulmonaryRespiratory Medicine
2019English

EXPRESS: Anticoagulation in Pulmonary Arterial Hypertension: A Decision Analysis

Pulmonary Circulation
PulmonaryRespiratory Medicine
2019English

ETA-receptor Blockade and ETB-receptor Stimulation in Experimental Congenital Diaphragmatic Hernia

American Journal of Physiology - Lung Cellular and Molecular Physiology
PulmonaryRespiratory MedicinePhysiologyCell Biology
2000English

EXPRESS: Atrial Arrhythmias Are Associated With Increased Mortality in Pulmonary Arterial Hypertension

Pulmonary Circulation
PulmonaryRespiratory Medicine
2018English

Reduction of Pulmonary Arterial Hypertension (Pah)-Related Hospitalizations With Macitentan in the Randomized Controlled Trial Seraphin

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Right Ventricular Reverse Remodelling After Sildenafil in Pulmonary Arterial Hypertension

Heart
Cardiovascular MedicineCardiology
2006English

EXPRESS: Sugen-Morphine (SuMo) Model of Pulmonary Arterial Hypertension

Pulmonary Circulation
PulmonaryRespiratory Medicine
2020English

Correction to Figures In: Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy